Search

Search Constraints

You searched for: Author/Creator Antman, Elliott M

Search Results

1. Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial. Issue 9984 (6th June 2015)

3. Edoxaban and implantable cardiac device interventions: insights from the ENGAGE AF-TIMI 48 trial. Issue 2 (19th November 2018)

4. Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF–TIMI 48. Issue 2 (1st March 2019)

5. Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF–TIMI 48. Issue 2 (March 2019)

6. Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial. Issue 3 (5th November 2019)

7. Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial. Issue 9984 (6th June 2015)

10. Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48. Issue 7 (28th December 2021)